Pediatric Hematology

1
Pediatric Hematology
Dr. Mariana Silva MD.F.R.C.P.C. March 2008
2
FETAL AND NEONATAL ERYTHROPOIESIS

• TABLE 1. Globin-chain development and composition

a This tetramer may be an epsilon tetrad. b
Fetal hemoglobin produced by adults has a
different amino acid heterogeneity of the gamma
chain at the 136 position than fetal hemoglobin
3
Site of Erythropoiesis
4
Hemoglobin Synthesis inFetus and Newborn

• Gower 1 and 2
• - present in yolk sac
• - 75 of early Hgb
• - undetectable after week 12
• Week 12 to 32 90 Hgb F

5
Hemoglobin Synthesis inFetus and Newborn (contd)

• The Switch is Hgb F to A
• Hgb F after week 32 by week 40 is 50-75
• by 6 month is 5-8 by 1 year lt 1
• Delayed Switch ( mechanism Stress
  Erythropoiesis)
• . Maternal hypoxia
• . Small for Gestational Age
• . Infants of diabetic mothers

6
Physiological Anemia of Infancy

• Gradual in Hgb after birth for 2 months
• stable 2-4 month then
• Physiologic as no symptoms of hypoxia and
• not nutritional
• Fetus - 10 weeks Hgb 9 gr/dl
• - 22-24 week Hgb 14 gr/dl
• - 32-40 week Hgb 16 gr/dl

7
Physiological Anemia of Infancy (contd)

• age blood supply to placenta Epo to
  maintain oxygen supply to infant Hemoglobin
  (Hgb)
• Oxygen delivery to fetus determines Hgb level at
  birth.
• Examples
• Small for gestational
• Infant of diabetic mother metabolic demands on
  fetus from glucose oxygen needs Hemoglobin
• Infants of smokers fetal CO oxygen
• available Hemoglobin to compensate
• Infants gestated at altitudes inspired
• oxygen by mothers Hemoglobin in newborn

8
Physiological Anemia of Infancy (contd)

• Birth Hemoglobin (Hgb) due to placental
  transfusion
• RBC production after birth due to
  availability
• of extrauterine oxygen
• 2 month of age Hgb due to RBC production
• shorter life fetal RBC
• Nadir at 7-9 wk of age Hgb 11 gr./dl

9
Physiological Anemia of Infancy (contd)

• placental transfusion in
• placenta previa or abruptio
• multiple gestation
• cord clamping lt 30 seconds
• C-section
• Cord around neck
• 24-32 week retics are 15 of RBCs at birth 7
• Day 7 retics to 1

10
Postnatal changes in hemoglobin and
ared-blood-cell indices in term infants
11
Anemia of Prematurity

• Premature Infant more rapid decline and lower
• nadir of Hgb than term
• 40 infants lt33 weeks show symptoms of anemia
• Epo rapidly Epo levels 50 lt than adults at
• same Hgb level
• Epo slowly as Hgb falls in premature babies
• Epo produced in liver

12
Anemia of Prematurity (contd)

• Decision to transfuse controversy for last
• 30 years
• Anemia risk of apnea and failure to thrive.
• Transfusion at predetermined Hgb level not cost
  effective and doesnt apnea

13
Sites and Timing of Neonatal Blood Loss

• A Fetus
• 1. Internal hemorrhage
• 2. Fetomaternal Hemorrhage
• 3. Fetoplacental hemorrhage
• abruptionprevia marginal sinus
  or hematoma
• 4. Twin-twin transfusion chronic

14
Sites and Timing of Neonatal Blood Loss (cont.)

• B Newborn
• 1. Twin-Twin transfusion acute
• 2. Umbilical-cord rupture or hematoma-normal
• or abnormal cord
• 3. Internal hemorrhage Intracranial hepatic
  or
• splenic rupture or hematoma adrenal
  or
• retroperitoneal hematoma. Pulmonary
  bleed
• 4. Placental trapping caesarean section early
  
• cord clamping precipitous delivery

15
Fe Deficiency Anemia

• Most common etiology of anemia
• Lack of dietary iron
• Contributing factors in children
  Rapid growth
• 
  Insufficient Fe
• Absorption
• Blood loss
• Breast milk or formula vs. cows milk
• Diet Cereals
• Meat

16
Fe Deficiency Anemia (contd)

• Lab Hemoglobin
• MCV
• Serum Fe/TIBC
• Serum Ferritin
• Platelets frequently
• Trial of Fe
• Treatment Oral ferrous sulfate 5-6 mg/kg of
  elemental Fe x day x 3 months
• Side effects of Fe

17
THROMBOPOIESIS IN FETUS AND NEWBORN
18
Thrombopoiesis

• I Yolk sac phase
• small megakaryocytes by 5 week
• platelets large and hypogranular
• II Hepatic phase
• early stage by 6 week
• Megakaryoblasts and promegakaryocytes seen
• late stage 9-11 weeks
• Megakaryocytes comparable to adult but
  smaller

19
Thrombopoiesis (contd)

• III Bone Marrow phase after 11 weeks
• from 11 to 22 stable number megakaryocytes then
  22 to
• 40 week.
• Size still small adult size by one year of
  age.
• Newborns easily develop thrombocytopenia due to
  
• sepsis. Little is known of newborn
• megakaryocytopoietic-thrombopoietic capacity

20
WELL
Large platelets Normal hemoglobin
and WBC
Small Platelets Congenital anomalies Mean
corpuscular volume
Consumption
Synthesis
Immune
Congenital
ITP 2 to
SLE HIV Drug Induced
TAR
Wiskott-Aldrich Syndrome
X-linked Amegakaryocytic
Fanconi anemia
Maternal ITP NATP
Non-immune
2B or platelet-type vWd Hereditary
macrothrombocytopenia
Acquired MedicationsToxinsRadiation
21
ILL
Fibrinogen Fibrin degradation
products Large
platelets
Small platelets HSM
Mass
Synthesis
Consumption
Microangiopathy Hemolytic-uremic
syndrome TTP
Malignancy Storage disease
Sequestration
Disseminated intravascular coagulation
Necrotizing enterocolitis
Respiratory distress Thrombosis
UAC
Sepsis
Viral infection
Hemangioma
Hypersplenism
22
Thrombocytopenia

• Infant Factors
• Platelet lt 100000/mm3 in 80 sick
  infants 60
• known etiology
• 22 infants in NICU have platelets
• Approximately 25 have significant
  bleeding
• platelets associated with sepsis respiratory
  distress bilirubin ventilation
• asphyxia meconium hypothermia
  pulmonary
• hypertension polycythemia
• Sepsis 52-77 have platelets
• may be 1st manifestation. Mean
• duration 5 days.

23
CLINICAL CASES

• I Tyler is an 11- month- old boy brought to your
  office by his mother who thinks he is pale and a
  bit irritable.
• He has not had any recent illnesses and is on no
  medications.
• History of presenting complaint
• Past medical history
• Diet
• Family History
• Physical Exam

24
LAB

• Hb 82 g/L
• MVC 65
• WBC 6.9 x 109/L
• Platelets 540000 x 109/L
• Possible diagnosis
• Treatment

25
CLINICAL CASES (contd)

• II Amanda is a 2-month-old girl you are seeing
  today for her lst immunization. Her mother
  reports that Amanda sleeps a lot and looks pale.
  She is growing well and breastfeeds vigorously.
• She is on no medications.
• History of presenting complaint
• Past medical history
• diet
• Family history
• Physical exam

26
LAB
0

• Hb 102 g/L
• MCV 84
• WBC 8.3 x 109/L
• Platelets 240000 x 109/L
• Possible diagnosis
• How would you manage this patient

27
Pancytopenia

• Reduction below normal values of 3 blood lines
• Leukocytes Platelets Erythrocytes
• Hypocellular Marrow Seen in
• Constitiutional (Inherited) marrow failure
  syndromes
• Acquired Aplastic Anemia
• Hypoplastic Variant of Myelodysplastic Syndromes

28
Pancytopenia (cont)

• Cellular marrow seen in
• Primary bone marrow disease as Acute Leukemia
  MDS Myelofibrosis
• Secondary to systemic disease autoimmune disease
  (SLE) Vitamin B12 or folate deficiency storage
  disease metastatic solid tumors etc.

29
Constitutional (Inherited) Pancytopenia Syndromes

• Fanconi Anemia
• Shwachman-Diamond Syndrome
• Dyskeratosis Congenita
• Amegakaryocytic Thrombocytopenia
• Other Genetic Syndromes
• Down Syndrome
• Dubowitz Syndrome
• Seckel Syndrome
• Reticular Dysgenesis
• Schimke Immuno-Osseous Dysplasia
• Familial Aplastic Anemia (non-Fanconi)
• Pearson Syndrome
• Reticular Dysgenesis
• Noonan Syndrome

30
Fanconi (Aplastic) Anemia

• Autosomal recessive syndrome
• Hematological findings
• Typical physical anomalies
• Abnormal chromosomal fragility

31
Characteristic Physical Anomalies in Fanconi
Anemia

• Anomaly
• Skin Pigment Changes
• Short Stature
• Upper Limb Abnormalities (thumbshandsradiulnas)
  
• Hypogonadal and Genital Changes (mostly males)
• Other Skeletal Findings (head/faceneckspine)
• Eye/lid/epicanthal fold anomalies
• Renal Malformations
• Ear Anomalies (external internal) deafness
• Hip leg foot toe abnormalities
• Gastrointestional/cardiopulmonary malformations

• Approximate Frequency
• ( of Patients)
• 65
• 60
• 50
• 40
• 30
• 25
• 25
• 10
• 10
• 10

32
(No Transcript)
33
Marrow Failure Before Age 10 Years

• Thrombocytopenia often first
• Granulocytopenia
• Macrocytic Anemia
• Severe Aplastic Anemia in Most Cases
• Increased Propensity for Cancer Carcinomas of
  Head Neck Carcinoma of Vulva and Anus

34
Treatment

• Transfusions
• Hematolpoietic Stem Cell Transplant is only
  Curative Treatment
• Androgens Prednisone
• Prognosis Median Survival is gt30 years of Age